This was the stock's second consecutive day of losses.

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $138.62, which the company reached on March 31st ...

Cardinal Health (CAH) has surged to a new 52-week high of $136.44 per share, reflecting a robust ascent that defies the ...

Cardinal Health's stock has surged 133% since May 2022, but its long-term chart reveals a history of prolonged correction.

Cardinal Health (NYSE:CAH – Get Free Report) had its price target boosted by equities research analysts at Mizuho from ...

Year-Old. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks ...

Complaints provide insights to improve product quality, ensure compliance, and drive growth. Cardinal Health is transforming ...

The latest trading session saw Cardinal Health (CAH) ending at $137.09, denoting a -1.14% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a loss of 4.84% for ...

The latest trading session saw Cardinal Health (CAH) ending at $137.09, denoting a -1.14% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a loss of 4.84% for the ...

Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside ...

Over the past year, many Cardinal Health, Inc. (NYSE:CAH) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually ...